ENTPD1 and esophageal squamous cell carcinoma: IL-6 has been also shown to induce CD39 expression in tumor-infiltrating NK cells in esophageal squamous cell carcinoma, suggesting a broad IL-6-mediated mechanism regulating CD39 expression in several immune cells [73].